Skip to main content

Posts

Showing posts from August, 2021

How to protect the diversion of controlled substances?

Nearly 15% of drug diversions happen from within healthcare workers. Working with a health care facility offers easy access to controlled substance drugs. Addiction makes you forget the fears of putting your health at risk and your responsibilities towards society. To protect this kind of diversion DEA has made rules to abide by compliance to decrease the chances of the misuse of controlled substances. Most of the controlled substance diversions happen from within the folds of the strictly regulated medical facilities. The work of a medical provider enables an easy procurement of controlled substances, and if perchance they were used for a medical reason the lingering effect of the same drug can happen even after the treatment is over. Hospitals need constant monitoring to ensure that drug diversion is not taking place. Controlled substance drugs are meant for patients who are experiencing unbearable pain from various illnesses. They may or may not be chronic. The DEA expects all med

Stricter Rules Binding Prescription and Disbursing Controlled Substance Drugs

The new regulations rolled out from January 2021 sets stricter compliance policies for controlled substance prescribers and pharmacists. Here is an understanding of what will keep pharmacists safe from violating the rules. Pharmacists are aware of the controlled substance prescription and their legitimate use for certain specialized illnesses. The responsibility of prescribing drugs and dispensing drugs is shared both by the practitioner and the pharmacist. The Drug Enforcement Administration, DEA controlled substance regulation and Federal Controlled Substances Act (“CSA”) have guidance that expects the pharmacist to exercise professional judgement on the prescription's legitimacy before the substance is dispensed to the patients. Prescription compliance and dispensing procedure have been bound in new compliance requirements by the State board Pharmacy and DEA. In California, the controlled prescription should carry identifying markers. After 2019 January all prescriptions should